Detalhe da pesquisa
1.
Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting.
Future Oncol
; 17(19): 2439-2448, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769073
2.
A call to action to advance patient-focused and decentralized clinical trials.
Cancer
; 130(8): 1193-1203, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193828
3.
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Oncologist
; 24(12): e1409-e1416, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420467
4.
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
Cancer
; 124(11): 2355-2364, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29645086
5.
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Oncologist
; 22(12): 1427-e129, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935773
6.
Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancers.
Invest New Drugs
; 35(5): 627-633, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283779
7.
Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice.
JCO Oncol Pract
; 20(2): 262-267, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369093
8.
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen.
Breast Cancer Res Treat
; 137(2): 457-64, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23224144
9.
Sorafenib and everolimus in advanced clear cell renal carcinoma: a phase I/II trial of the SCRI Oncology Research Consortium.
Cancer Invest
; 31(5): 323-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23614653
10.
Sustainable Integration of US Food and Drug Administration-Approved Biosimilars: Pharmacy- Versus Physician-Driven Change.
JCO Oncol Pract
; 19(11): 1053-1057, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738533
11.
Closing the Testing Gap: Standardization of Comprehensive Biomarker Testing for Metastatic Non-Small-Cell Lung Cancer in a Large Community Oncology Practice.
JCO Oncol Pract
; 19(6): e951-e956, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126768
12.
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy.
J Thorac Oncol
; 18(7): 907-921, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36842467
13.
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer.
Invest New Drugs
; 30(2): 772-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21120580
14.
Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community Oncologists.
Clin Lung Cancer
; 22(6): e901-e910, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34187757
15.
Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics.
Onco Targets Ther
; 14: 5321-5331, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853516
16.
Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement.
JCO Oncol Pract
; 17(1): 41-51, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405975
17.
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer.
Drugs Real World Outcomes
; 7(4): 261-269, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32725539
18.
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
JCO Oncol Pract
; 16(7): 417-421, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396491
19.
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.
J Clin Oncol
; 38(33): 3863-3873, 2020 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910710
20.
Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer.
Clin Cancer Res
; 26(18): 4814-4822, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554514